Alger Health Sciences FundAHSCX
Type
Mutual fund
Peer group
US equity: Healthcare
Net assets
$60.9M
Expense ratio
1.96%
1-year return
+21.6%
3 years, a year
+2.9%
5 years, a year
+1.6%
Holdings
60
What it aims to do.
Alger Health Sciences Fund seeks long-term capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| TEVA Teva Pharmaceutical Industries Ltd | 4.58% |
| JOBY Impulse Dynamics Ireland | 4.57% |
| Forte Biosciences Inc | 4.28% |
| ARWR Arrowhead Pharmaceuticals Inc | 4.04% |
| WELL Welltower Inc | 3.23% |
| CAH Cardinal Health Inc | 3.22% |
| JNJ Johnson & Johnson | 2.99% |
| TWST Twist Bioscience Corp | 2.93% |
| MRK Merck & Company Inc | 2.89% |
| NKTR Nektar Therapeutics | 2.66% |
More on AHSCX.
- AHSCX overview
- AHSCX holdings
- AHSCX risk
- AHSCX costs
- AHSCX money in and out
- AHSCX share classes
- Compare AHSCX with other funds
Returns after fees, from the fund's SEC filings up to Apr 2026. Past returns are not a promise. Not financial advice.